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Peritoneal dialysis-related peritonitis: an analysis of risk factors
in Northeast Anatolia*
Mustafa KELEŞ1, Ramazan ÇETİNKAYA1, Abdullah UYANIK1, Hamit ACEMOĞLU2, Fatma EROĞLU3,
M. Hamidullah UYANIK4

Aim: Peritonitis is almost the most frequent complication of peritoneal dialysis (PD). Besides being the most frequent
reason of hospitalization, peritonitis is also the most important determining factor of mortality-morbidity and technique
survival among PD patients. In this study, it was aimed to identify the risk factors for peritonitis in these patients.
Materials and methods: In this clinical cohort, records of 218 patients were collected between January 1998 and
December 2007. The patients’ demographic, clinical, and laboratory parameters were recorded. Results were analyzed to
compare patients who never had peritonitis and patients with at least one episode of peritonitis. Independent predictors
of peritonitis were assessed using Cox regression, and the hazard ratio (HR) was determined using 95% confidence
interval (95% CI).
Results: Of over 6304 patient-months, 337 episodes of peritonitis were observed. The overall peritonitis rate was 0.64
attack/year. The risk of peritonitis was lower for PD patients with each 1 g/dL increase in mean albumin levels (HR, 0.39;
95% CI, 0.24-0.65; P < 0.001). Variables identified to be associated with an increased likelihood of peritonitis were: the
placement of catheter via surgery (HR, 3.97; 95% CI, 2.16-7.29; P < 0.001), constipation (HR, 2.22; 95% CI, 1.26-3.92; P
< 0.01), and amyloidosis (HR, 1.81; 95% CI, 0.93-3.50; P = 0.078).
Conclusion: Hypoalbuminemia, constipation, the placement of catheter via surgery, and amyloidosis were found to
increase the risk of peritonitis in the present study. Such risk factors should be kept in mind during follow-up of patients
under PD.
Key words: Peritoneal dialysis, peritonitis, risk factors

Periton diyalizi ile ilişkili peritonit: Kuzeydoğu Anadolu’da risk faktörlerinin analizi
Amaç: Periton Diyalizi (PD), son dönem böbrek yetmezlikli hastaların tedavisinde kullanılan renal replasman tedavi
seçeneklerinden biridir. Peritonit, PD’nin en sık görülen komplikasyonlarındandır. PD tedavisinde ve teknolojisinde
sağlanan gelişmeler nedeni ile peritonit sıklığında azalma olmasına rağmen peritonit hâlâ sorun olmaya devam
etmektedir. Bu çalışmada peritonit gelişmesinde etkili olan risk faktörlerinin araştırılması amaçlanmıştır.
Yöntem ve gereç: Bu klinik kohortta, Atatürk Üniversitesi Tıp Fakültesi Nefroloji Bilim Dalı’nda Ocak 1998-Aralık 2007
tarihleri arasında Periton Diyalizi Ünitesi’nde takip edilen toplam 218 hastanın dosyaları retrospektif olarak incelendi.
Hastaların demografik, klinik ve laboratuar sonuçları kaydedildi. Hastalar, hiç peritonit geçirmeyenler peritonitsiz grup
ve en az bir veya daha fazla peritonit geçirenler peritonitli grup olmak üzere 2 gruba ayrıldı. Peritonitle ilgili risk
faktörlerini saptamak için Cox regresyon analizi yapıldı, % 95 güven aralığında (GA) "hazard ratio" (HR: Zararlanma
oranı) hesaplandı.
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Bulgular: Toplam 6304 periton diyaliz ayında 337 peritonit atağı gözlendi. Ortalama peritonit sıklığı 0.64 atak/yıl olarak
bulundu. PD hastalarında ortalama albümin düzeyi artıkça peritonit riski 0.39 kat (% 95 GA 0,24 – 0,65; P < 0,001)
azalmaktaydı. PD kataterinin cerrahi yöntemle takılması peritonit riskini 3,97 kat (% 95 GA 2,16 - 7,29; P < 0.001),
hastalarda konstipasyon olması 2,22 kat (% 95 GA 1,26 - 3,92; P < 0.01), amiloidozun olması 1,81 kat (% 95 GA 0,93 3,50; P = 0,078) artırmaktaydı.
Sonuç: Sonuç olarak, bu çalışmada hipoalbüminemi, konstipasyon, PD kateterinin cerrahi yöntemle takılması ve
amiloidoz peritonit gelişimi için bir risk faktörü olarak tespit edilmiştir. Bu risk faktörleri hastaların takip edilmesinde
göz önünde bulundurulmalıdır.
Anahtar sözcükler: Periton diyalizi, peritonit, risk faktörleri.

Introduction

Patients and methods

Peritoneal dialysis (PD) is an established treatment
modality in end-stage renal disease (ESRD) patients
and 150,000 patients are being maintained on PD
worldwide (1). Peritonitis is one of the most common
complications of PD. Peritonitis, once the most feared
complication of PD treatment, remains an issue
although there has been a reduction in the incidence
rate with recent advances in PD treatment and
technologies (2). Besides being the most frequent cause
of hospitalization in patients receiving PD, peritonitis
is also among the major factors leading to catheter loss
and initiating hemodialysis therapy. In addition,
peritonitis induces dysfunction in the peritoneal
membrane, adversely affecting PD survival and leading
to rapid loss of residual renal functions in the long term.
Thus, peritonitis seems to be the most important
determinant of mortality, morbidity, and technique
survival in PD patients (3–5). Rates of peritonitis vary
significantly, both among countries and among centers
in the same country. This variability may be due to
patients’ age, gender, race, genetics, educational status,
and geographical factors, and may also be associated
with peritoneal dialysis materials and the level of
training provided by centers to both patients and their
staff (6). Therefore, each center should establish its own
risk profile and develop strategies accordingly.

Our PD center is located in the Eastern Anatolia
and serves as a reference center in this area.
Consecutive patients initiating PD from January 1998
to December 2007 were analyzed in this clinical
cohort study. All procedures followed the tenets of the
Declaration of Helsinki. The study protocol was
approved by the Local Ethics Committee of Atatürk
University.

In this study, we aimed to investigate the risk
profile of patients with peritonitis in Eastern Anatolia
and to identify relevant measures in its prevention. As
our PD center serves to a wide area and the study
includes patients from this wide geographical region,
we are of the opinion that the results obtained in the
present study will provide significant guidance in
determining strategies related with the risk factors of
peritonitis.
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All patients followed by the PD unit of the Atatürk
University Nephrology Department were included in
the study. Patients below 18 years of age at the time
when PD was started and those with inadequate
compliance to the follow up schedule (maximum
follow up interval requested was 3 months) were all
excluded from the study. As a result, a total of 218
patients were included.
The patients were divided into 2 groups. The
peritonitis-free group included those who did not
experience a peritonitis attack, and the peritonitis
group included patients with at least one episode of
peritonitis during the treatment period. The diagnosis
of peritonitis-complicated PD was based on at least 2
of the following criteria: abdominal pain or cloudy PD
effluent, leukocytosis in peritoneal fluid effluent
(leukocyte count at least 100/mm3), positive Gram
stain or culture of effluent (7). Treatment of peritonitis
in all patients was based on the ISPD guidelines (7–9).
Analyses of cultures collected from all peritonitis
cases and other microbiologic tests were carried out at
the Microbiology Laboratory of Atatürk University
Faculty of Medicine.
The twin-bag system was employed in all patients
and different kinds of PD fluid (Baxter Healthcare and
Fresenius Medical Care) were used. Whether the
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patient had undergone HD, whether the patient could
perform PD alone or with assistance, as well as the use
of PD solutions (standard glucose solutions, solutions
containing icodextrin, and low-calcium solutions),
and the type of PD [continuous ambulatory peritoneal
dialysis (CAPD) or automated peritoneal dialysis
(APD)] were documented before initiating PD. It was
also determined whether the PD catheter was inserted
via open surgical technique or percutaneous Seldinger
technique. All patients had undergone cefazolin
prophylaxis before attaching the catheters.

Windows. Student’s t test for numeric variables and
the Chi-square test for categorical variables were used
to compare the 2 groups. Parameters yielding
significance at the level of P < 0.2 in the univariate
analysis were subjected to the Cox regression analysis
model to identify risk factors for peritonitis. The
backward elimination method was used for Cox
regression analysis and the hazard ratio was estimated
based on a 95% confidence interval. The level of
significance was set to P < 0.05.

ESRD and accompanying diseases were
documented. Patients’ hepatitis indicators (HBsAg and
Anti-HCV) were recorded from their files. Patients
were evaluated for constipation at each follow up visit
and those with less than 3 bowel movements per week
as well as those using laxatives for constipation were
considered to have constipation (10).

Results

Patients were categorized according to their
educational status as follows: those with high school
or university degrees were classified as “high school
and above” while others were referred to as “pre-high
school”. Patients living in an area with a population
less than 20,000 were categorized as rural residents
and those living in areas with a population 20,000 and
above were classified as urban residents (11). Patients’
age, sex, body surface area (BSA), and body mass
index (BMI) were obtained from their files.
Findings of blood-urea nitrogen (BUN), serum
creatinine (Cr), albumin, ferritin, and blood
hemoglobin (Hb) were recorded taking the average of
all recordings. All laboratory and other data were
recorded at the entry visit and then at each follow up
visit with an interval of 2-3 months. Values during
periods with peritonitis were excluded from the
analyses.
Adequacy of dialysis was estimated by
measurement of weekly Kt/V for urea and normalized
protein nitrogen appearance (nPNA), using standard
methods. The transport property of the peritoneal
membrane was determined by the standard peritoneal
equilibration test.
Statistical analyses
Data are presented as frequencies, percentages,
means, and standard deviations (SD). Statistical
analyses were carried out using SPSS 11.5 for

The mean age of the subjects was 47.9 ± 17.0 years.
One hundred and ten (50.5%) of the patients were
females and 108 (49.5%) were males. Of them, 50.5%
were living in rural areas and only 17.4% had an
educational level of high school and above. Table 1
details the baseline characteristics of 218 patients. The
causes of ESRD included diabetes mellitus (24.8%),
chronic
interstitial
nephritis
(22.5%),
glomerulonephritis (13.3%), hypertension (12.4%),
amyloidosis (11.0%), polycystic kidney disease (5.5%),
unknown (7.8%), and other (2.8%).
The patients were followed-up with a mean
duration of 28.0 ± 17.9 months. In 218 patients
enrolled, 337 peritonitis attacks were observed during
a total of 6304 patient-months. The mean frequency
of peritonitis was 0.64 attacks/year. Staphylococcus
coagulase-negative (39.2%) was the most common
causative organism (Table 2).
Patients were classified as peritonitis-free (n = 61)
and peritonitis group (n = 157). Table 1 presents the
differences between these 2 groups and provides a
univariate comparison of the patients’ demographic,
clinical, and laboratory findings. Peritonitis was
significantly more frequent in patients with pre-high
school educational levels (P = 0.011), amyloidosis
(borderline significance, P = 0.07), constipation (P =
0.002), undergoing HD before PD (P = 0.007), and
requiring assistance to perform PD (P = 0.05). Kt/V
urea and albumin values were significantly lower in
the group of patients with peritonitis (P = 0.04 and P
< 0.001, respectively). Albumin levels of patients with
amyloidosis (2.94 ± 0.59 g/dL) were significantly
lower than those without amyloidosis (3.18 ± 0.56
g/dL) (P = 0.047).
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Table 1. Comparison between peritonitis-free and peritonitis group.

Age (years)
Follow-up duration (months)
Peritonitis-free time (months)
Gender (male/female)
BMI (kg/m2)
BSA (m2)
Living in (rural:urban) areas
rural
urban
Educational status
Pre-high school
High school and above
Comorbidities
Diabetes mellitus
Hypertension
HBsAg (positivity)
Anti-HCV (positivity)
Amyloidosis
Constipation
Dialysis type
APD
CAPD
PD with assistance
HD before PD
PD catheter placement
Percutaneous
Surgical
PD solutions
Standard
Icodextrin
Low-calcium
Hemoglobin (g/dL)
Ferritin (ng/mL)
BUN (mg/dL)
Serum Cr (mg/dL)
Serum Albumin (g/dL)
Weekly total Kt/V urea
CrCl (L/week/1.73 m2)
2
GFR (L/week/1.73 m )
nPNA (g/kg/day)
Mean D/P creatinine

Peritonitis-free
(n=61)

Peritonitis
(n=157)

P

46.5 ± 15.2
28.0 ± 17.9
28.0 ± 17.9
31(50.8%)/30(49.2%)
24.01 ± 5.16
1.67 ± 0.20

48.5 ± 17.7
29.3 ± 19.0
12.24 ± 13.05
77(49%)/80(51%)
23.47 ± 4.81
1.66 ± 0.24

0.5
0.7
0.000
0.8
0.5
0.6

24 (39.3%)
37 (60.7%)

84 (53.5%)
73 (46.5%)

0.06

44 (72.1%)
17 (27.9%)

136 (86.6%)
21 (13.4%)

0.011

16 (26.2%)
50 (82%)
3 (4.9%)
4 (6.6%)
3 (4.9%)
2 (3.3%)

38 (24.2%)
121 (77.1%)
9 (5.7%)
11 (7%)
21 (13.4%)
31 (19.7%)

0.7
0.4
0.8
0.9
0.07
0.002

6 (9.8%)
55 (90.2%)
15 (24.6%)
30 (49.2%)

23 (14.6%)
134 (85.4%)
60 (38.2%)
108 (68.8%)

0.4

25 (41%)
36 (59%)

48 (30.6%)
109 (69.4%)

0.1

45 (73.8%)
12 (19.7%)
4 (6.6%)
10.65 ± 2.00
397.70 ± 346.81
49.06 ± 14.19
7.79 ± 2.71
3.42 ± 0.40
2.67 ± 1.11
95.46 ± 55.69
32.52 ± 18.95
1.37 ± 1.04
0.69 ± 0.10

121 (77.1%)
32 (20.4%)
4 (2.5%)
10.30 ± 1.96
461.39 ± 398.46
49.98 ± 16.22
7.49 ± 2.53
3.05 ± 0.60
2.30 ± 0.78
83.49 ± 56.27
25.74 ± 23.61
1.11 ± 0.64
0.71 ± 0.13

0.4

0.05
0.007

0.2
0.3
0.7
0.4
0.000
0.04
0.2
0.2
0.1
0.5

APD: Automated peritoneal dialysis, BMI: Body mass index, BSA: Body surface areas, BUN:
Blood-urea nitrogen, CAPD: Continuous ambulatory peritoneal dialysis, Cr: Creatinine, CrCl:
Creatinine clearance, D/P: Dialysate-to- plamsa ratio, GFR: Glomerular filtration rate, nPNA:
Normalized protein nitrogen appearance.
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Table 2. Micro-organisms in patients with peritonitis.
Causative organisms

n (%)

Gram-positive organisms
Coagulase-negative staphylococcus
Staphylococcus aureus
Alpha-hemolytic streptococci
Non-hemolytic streptococci
Streptococcus pneumoniae
Enterococcus sp.
Other
Gram-negative organisms
Escherichia coli
Enterobacter sp.
Pseudomonas aeruginosa
Other
Candida sp.
Mycobacterium tuberculosis
Culture negative
Total

132 (39.2%)
21 (6.2%)
17 (5.0%)
7 (2.1%)
6 (1.8%)
3 (0.9%)
4 (1.2%)

Table 3 demonstrates the results of the multivariate
analysis (Cox regression analysis). The risk of
peritonitis was lower for PD patients with each 1 g/dL
increase in mean albumin levels (HR, 0.39; 95% CI,
0.24-0.65; P < 0.001). The risk of peritonitis increased
3.97-fold (95% CI 2.16–7.29; P < 0.001) with surgical
insertion of the PD catheter, while presence of
constipation increased the risk 2.22 fold (95% CI
1.26–3.92; P < 0.01) and amyloidosis 1.81-fold (95%
CI 0.93–3.50; P = 0.078).
Discussion

20 (5.9%)
14 (4.2%)
7 (2.1%)
7 (2.1%)
7 (2.1%)
6 (1.8%)
86 (25.5%)
337 (100.0%)

Multivariate analysis
Results with P values less than 0.2 in univariate
analysis related to peritonitis development (serum
albumin level, constipation, HD prior to PD,
educational level, Kt/V urea, person performing PD,
place of residence, amyloidosis, and nPNA) were
evaluated using Cox regression analysis as a
multivariate analysis. Mean serum albumin level,
chronic constipation, surgical insertion of the PD
catheter, and presence of amyloidosis were identified
as the risk factors with multivariate analysis.

The results of the present study demonstrate the
increased risk of developing peritonitis with
hypoalbuminemia, constipation, surgical insertion of
dialysis catheter, and presence of amyloidosis.
Several studies have associated decreased albumin
levels with increased mortality and morbidity (12,13).
A study by Young et al. (14) reported an increased
frequency of peritonitis and longer hospitalization
periods in CAPD patients with lower levels of serum
albumin. The authors associated this with
impairments in the humoral mechanisms. A similar
study by Spiegel et al. (15) demonstrated increases in
the frequency of hospitalization in patients with low
serum albumin levels. Prasad et al. (16) identified a
significant relationship between serum albumin levels
and peritonitis attacks, and described serum albumin
level as an important indicator of peritonitis
development. A multi-center prospective study by the
CANUSA Peritoneal Dialysis Study Group (17)
demonstrated a negative relationship between serum
albumin concentrations and mortality, technique
survival, and hospitalization. In studies categorizing
PD patients into peritonitis-free and peritonitis

Table 3. Multivariate Cox regression analysis showing factors associated with dialysis-related peritonitis.

Serum albumin (per 1 g/dL increase)

HR (95% CI) of developing peritonitis

P

0.39 (0.24-0.65)

0.000

PD catheter placement (via surgery)

3.97 (2.16-7.29)

0.000

Constipation

2.22 (1.26-3.92)

0.006

Amyloidosis

1.81 (0.93-3.50)

0.078

CI: confidence interval, HR: Hazard ratio.
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groups (16,18,19), albumin levels of patients in the
peritonitis group were lower, similar to the results of
our study. The multivariate analysis of the present
study demonstrated a significant reduction in the risk
of developing peritonitis with increased levels of
serum albumin. Increased risk of developing
peritonitis with hypoalbuminemia may be associated
with a compromised immune response as a result of
hypoalbuminemia and malnutrition (14,16).
The efficiency of PD catheters depends on their
insertion technique rather than their design (20). In a
retrospective study evaluating outcomes of PD
patients, Ozener et al. (21) observed significantly
decreased frequency of peritonitis in patients who
were catheterized using the percutaneous technique
compared to those who underwent surgical
catheterization. However, Roueff et al. (22) noted no
significant differences between these 2 techniques in
terms of peritonitis. A meta-analysis by Ash (20) of
70 trials evaluated complications associated with
catheterization and reported a frequency of 24% for
catheter-related infections with the percutaneous
method, while the frequency was 35% with surgical
catheterization. In our study, the multivariate analysis
showed a 3.97-fold increase in the risk of developing
peritonitis with the surgical method. The lower risk
of peritonitis with the percutaneous method may be
associated with the smaller incision area and less
muscular and peritoneal trauma as mentioned by Ash
(20). Long term controlled studies are needed in order
to make stronger deductions in this issue.
Constipation develops in PD patients due to
decreased fiber content in consumed foods, reduced
liquid intake, electrolyte imbalance, phosphate
binders containing aluminum, and calcium and iron
preparations. Decreased activity and underlying
diseases in these patients also contribute to
constipation (23). In our study, the multivariate
analysis demonstrated a 2.22-fold increase in the risk
of developing peritonitis in the presence of
constipation. Singharetnam et al. (24) evaluated PD
patients hospitalized for non-peritonitis reasons and
reported the occurrence of peritonitis within 48 h in
5 patients with a history of chronic constipation who
had received laxatives after admission. They
associated this with irritation and infection of the
peritoneal membrane due to transmural migration of
648

enteric microorganisms caused by rapid treatment of
constipation. Suh et al. (25) reported endogenous
peritonitis in 15 of 192 PD patients, and identified
that 11 had severe constipation prior to peritonitis.
All our subjects received oral treatment for
constipation. Occurrence of peritonitis in patients
with constipation may be due to transmural migration
of enteric microorganisms during constipation
treatment, whereas it may also be associated with
increased penetration of enteric microorganisms
resulting from decreased intestinal flow. We thought
that more comprehensive prospective studies are
required to elucidate this issue.
In a study comparing outcomes of PD patients
with and without amyloidosis, Altiparmak et al. (26)
noted no significant differences between these 2
patient groups in terms of peritonitis. A further study
by Sahin et al. (27) comparing PD patients and HD
patients with amyloidosis reported more frequent
infections in PD patients, most of which were
peritonitis. In our study, the multivariate analysis of
patients with amyloidosis regarding occurrence of
peritonitis demonstrated a 1.81-fold increase in the
risk of developing peritonitis (borderline
significance). However, other systemic effects and
hypoalbuminemia in patients with amyloidosis may
be considered as significant factors regarding
infection susceptibility.
Diabetes mellitus is one of primary causes of renal
failure in patients undergoing renal replacement
therapy due to ESRD worldwide (28). Conflicting data
have been reported regarding differences between
diabetic and non-diabetic patients in terms of
incidence of peritonitis. Some studies with PD patients
have reported diabetes mellitus as a risk factor for
peritonitis (18,19,29), and this has been associated with
compromised immune response in the defense system
of the peritoneum in PD patients with diabetes mellitus
(18). In some large studies, on the other hand, diabetes
mellitus was not described as a risk factor for
developing peritonitis (30,31). In accordance with the
above findings, diabetes mellitus was not found to be a
risk factor for peritonitis in our study.
In conclusion, our study demonstrated that
hypoalbuminemia, constipation, surgical insertion of
the dialysis catheter, and presence of amyloidosis were
risk factors for developing peritonitis in PD patients.
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Prevention and treatment of hypoalbuminemia in PD
patients is important in minimizing the potential risk
of peritonitis. Percutaneous placement of the PD
catheter seems to be a safe and advantageous method.
Associated with less trauma and lower incidence of
peritonitis, the percutaneous technique should be
used for patients wherever applicable. Preventing
constipation, maintaining a balanced diet, and

ensuring liquid-electrolyte balance are important in
preventing the risk of peritonitis in PD patients.
Monitoring the patients closely against possible
occurrence of peritonitis, particularly in those with
amyloidosis, should be considered. Further
prospective studies are needed to support our
findings. We suggest each PD center study their own
risk factors and develop appropriate strategies.
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